BSX Q1 2025 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4.7B+20.9% YoY

Gross Profit

$3.0B63.3% margin

Operating Income

$896M19.2% margin

Net Income

$674M14.5% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

$541M

Free Cash Flow

$354M

Stock-Based Comp.

$74M

Balance Sheet

Total Assets

$40.1B

Total Liabilities

$17.7B

Stockholders' Equity

$22.2B

Cash & Equivalents

$725M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$3.9B	+20.9%
Gross Profit	$3.0B	$2.4B	+23.7%
Operating Income	$896M	$644M	+39.1%
Net Income	$674M	$494M	+36.4%

Revenue Segments

Cardiovascular

$3.1B66%

MedSurg

$1.6B34%

Geographic Segments

UNITED STATES

$3.0B63%

Non-US

$1.7B37%